Shenzhen, Guangdong, China In 1998 was created SalubrisBio, which is appeared as Corporate Investor. The company was established in Asia in China. The leading representative office of defined Corporate Investor is situated in the Shenzhen.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2018. The fund is generally included in less than 2 deals every year. The real fund results show that this Corporate Investor is 55 percentage points more often commits exit comparing to other companies.
The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Health Care, Biopharma. Among the most popular portfolio startups of the fund, we may highlight Viracta Therapeutics, GO Therapeutics, KingstronBio. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the SalubrisBio, startups are often financed by Latterell Venture Partners, Forward Ventures, Crocker Capital. In the next rounds fund is usually obtained by Taiwania Capital.
Related Funds
| Fund Name | Location |
| 10K Ventures | Berlin, Berlin, Germany |
| American International Group | New York, New York, United States |
| Berkeley Angel Network | California, San Francisco, United States |
| BioMotiv | Cleveland, Ohio, United States |
| CABRA VC | California, Los Angeles, United States |
| CFO Rick, Inc. | California, San Francisco, United States |
| Daimler Trucks North America | Oregon, Portland, United States |
| Edventures | Boise, Idaho, United States |
| Mountain Trail Investments | California, Los Angeles, United States |
| Oracle Investment Management Inc. | Connecticut, Greenwich, United States |
| Oval Park Capital | North Carolina, Raleigh, United States |
| Quality Jobs Fund (QJF) | - |
| RENN Capital | Dallas, Texas, United States |
| Rose Ventures | Madison, United States, Wisconsin |
| Slingshot Accelerator | Australia, New South Wales, Sydney |
| Toscafund Asset Management | England, London, United Kingdom |
| Transdev | France, Ile-de-France, Issy-les-moulineaux |
| Yael Capital Management Limited | - |
| Zell Lurie Commercialization Fund | Ann Arbor, Michigan, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SalubrisBio | $35M | 22 Apr 2024 | Gaithersburg, Maryland, United States | ||
Core Medical Technology | 30 Dec 2022 | Shenzhen, Guangdong, China | |||
KingstronBio | $19M | 22 Jan 2018 | China, Wuwei | ||
Zhongke Jiankang Wang | $463K | 23 Dec 2016 | Xuanwu District, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SalubrisBio | $35M | 22 Apr 2024 | Gaithersburg, Maryland, United States | ||
Core Medical Technology | 30 Dec 2022 | Shenzhen, Guangdong, China | |||
KingstronBio | $19M | 22 Jan 2018 | China, Wuwei | ||
Zhongke Jiankang Wang | $463K | 23 Dec 2016 | Xuanwu District, Jiangsu, China |
